Back to results
US 12,310,395 B1Granted
Oral formulations of kava and nicotine
OwnerJerry Wayne Rossinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are oral formulations comprising a nicotine composition and/or a kava composition. The oral formulations comprising a nicotine composition and/or a kava composition disclosed herein may be formulated as a chewable tablet, a lozenge, a chewing gum, a dissolvable oral strip, or a pouch. Also disclosed herein are methods for making a chewable tablet, a lozenge, a chewing gum, a dissolvable oral strip, or a pouch comprising a nicotine composition and/or a kava composition.
Claims17
An oral formulation comprising:
- (i) an amount of a nicotine composition;
- wherein the nicotine composition comprises at least one compound selected from the group consisting of nicotine, nicotine acetate, nicotine benzoate, nicotine bitartrate, nicotine bitartrate dihydrate, nicotine citrate, nicotine dihydrochloride, nicotine formate, nicotine hydrochloride, nicotine lactate, nicotine laurate, nicotine levulinate, nicotine malate, nicotine polacrilex, nicotine pyruvate, nicotine salicylate, nicotine sorbate, nicotine succinate, nicotine sulphate, nicotine tartrate, and nicotine zinc chloride monohydrate;
- and
- (ii) an amount of a kava composition;
- wherein the kava composition comprises between about 225 mg and about 900 mg of kavalactones;
- and
- wherein the kavalactones comprise an amount of kavain, an amount of dihydrokavain, and optionally, an amount of methysticin, an amount of dihydromethysticin, an amount yangonin, and an amount of desmethoxyyangonin.
4 more elements
An oral pouch comprising:
- (i) between about 3 mg and about 20 mg of at least one compound selected from the group consisting of nicotine, nicotine acetate, nicotine benzoate, nicotine bitartrate, nicotine bitartrate dihydrate, nicotine citrate, nicotine dihydrochloride, nicotine formate, nicotine hydrochloride, nicotine lactate, nicotine laurate, nicotine levulinate, nicotine malate, nicotine polacrilex, nicotine pyruvate, nicotine salicylate, nicotine sorbate, nicotine succinate, nicotine sulphate, nicotine tartrate, and nicotine zinc chloride monohydrate;
- (ii) between about 5 mg and about 20 mg of a high intensity sweetener;
- (iii) between about 100 mg and about 200 mg of a filler;
- (iv) between about 25 mg and about 75 mg of a flavorant;
- and
- (v) between about 200 mg and about 300 mg of a paste;
- wherein the paste comprises between about 68% wt. and about 90% wt. kavalactones;
- and
- wherein the kavalactones comprise an amount of kavain, an amount of dihydrokavain, and optionally, an amount of methysticin, an amount of dihydromethysticin, an amount yangonin, and an amount of desmethoxyyangonin.
6 more elements
Dependencies are inferred from the claim text.